AST is a novel anti-carcinogenic regimen against gastrointestinal cancer development with unique molecular targets (Abstract)

Joshua Ko*, Kathy K W Auyeung

*Corresponding author for this work

Research output: Contribution to journal › Conference article › peer-review

Fingerprint

Dive into the research topics of 'AST is a novel anti-carcinogenic regimen against gastrointestinal cancer development with unique molecular targets (Abstract)'. Together they form a unique fingerprint.

Chemical Compounds